Should I buy or sell Aveanna Healthcare stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" AVAH shares. View AVAH analyst ratings or view top-rated stocks .

What is Aveanna Healthcare's stock price target for 2024?

6 brokerages have issued 12-month price targets for Aveanna Healthcare's shares. Their AVAH share price targets range from $1.00 to $3.00. On average, they predict the company's share price to reach $1.80 in the next year. This suggests that the stock has a possible downside of 21.4%. View analysts price targets for AVAH or view top-rated stocks among Wall Street analysts .

How have AVAH shares performed in 2024?

Aveanna Healthcare's stock was trading at $2.68 at the beginning of 2024. Since then, AVAH stock has decreased by 14.6% and is now trading at $2.29. View the best growth stocks for 2024 here .

When is Aveanna Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our AVAH earnings forecast .

How can I listen to Aveanna Healthcare's earnings call?

Aveanna Healthcare will be holding an earnings conference call on Thursday, May 9th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13745298".

How were Aveanna Healthcare's earnings last quarter?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) announced its quarterly earnings data on Thursday, March, 14th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. The business earned $478.84 million during the quarter, compared to analyst estimates of $464.33 million.

What guidance has Aveanna Healthcare issued on next quarter's earnings?

Aveanna Healthcare updated its FY 2024 earnings guidance on Thursday, March, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $2.0 billion.

When did Aveanna Healthcare IPO?

Aveanna Healthcare (AVAH) raised $478 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse acted as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

How do I buy shares of Aveanna Healthcare?

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:AVAH

Aveanna Healthcare (AVAH) Stock Price, News & Analysis

→ Urgent alert: open this for a huge profit potential (From Timothy Sykes) (Ad)

Free AVAH Stock Alerts

$2.29

+0.13 (+6.02%)

(As of 04/19/2024 ET)

Compare

Today's Range: $2.14
▼
$2.29
50-Day Range: $2.16
▼
$2.61
52-Week Range: $0.85
▼
$3.00

Volume: 150,838 shs
Average Volume: 97,385 shs
Market Capitalization: $440.55 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $1.80

Get Aveanna Healthcare alerts:

Aveanna Healthcare MarketRank™ Stock Analysis

Analyst Rating: Reduce
1.67 Rating Score
Upside/Downside: 21.4% Downside
$1.80 Price Target
Short Interest: Bearish
2.02% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.26
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.13) to ($0.07) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.09 out of 5 stars

Medical Sector

902nd out of 911 stocks

Home Health Care Services Industry

8th out of 8 stocks

0.8

Analyst's Opinion

Consensus Rating
Aveanna Healthcare has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on 1 buy rating, 2 hold ratings, and 3 sell ratings.
Amount of Analyst Coverage
Aveanna Healthcare has only been the subject of 1 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
2.02% of the float of Aveanna Healthcare has been sold short.
Short Interest Ratio / Days to Cover
Aveanna Healthcare has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.
Change versus previous month

0.0

Dividend Strength

Dividend Yield
Aveanna Healthcare does not currently pay a dividend.
Dividend Growth
Aveanna Healthcare does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AVAH.

1.8

News and Social Media Coverage

News Sentiment
Aveanna Healthcare has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Aveanna Healthcare this week, compared to 1 article on an average week.
Search Interest
Only 2 people have searched for AVAH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Aveanna Healthcare insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 7.80% of the stock of Aveanna Healthcare is held by insiders.
Percentage Held by Institutions
87.96% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Aveanna Healthcare are expected to grow in the coming year, from ($0.13) to ($0.07) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Aveanna Healthcare is -3.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Aveanna Healthcare is -3.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Aveanna Healthcare Stock (NASDAQ:AVAH)

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

AVAH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AVAH Stock News Headlines

April 18, 2024 | globenewswire.com

Aveanna Announces First Quarter 2024 Earnings Release Date and Conference Call

April 13, 2024 | morningstar.com

Aveanna Healthcare Holdings Inc

April 20, 2024 | Timothy Sykes (Ad)

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

April 12, 2024 | investing.com

Aveanna Healthcare Holdings Inc (AVAH)

April 12, 2024 | americanbankingnews.com

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus Recommendation of "Reduce" from Analysts

April 11, 2024 | finance.yahoo.com

Breakeven On The Horizon For Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

April 5, 2024 | uk.investing.com

Aveanna Healthcare names new Chief Legal Officer

April 3, 2024 | globenewswire.com

Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary

April 20, 2024 | Timothy Sykes (Ad)

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

March 21, 2024 | businesswire.com

Federman & Sherwood Investigates Aveanna Healthcare for Data Breach

March 16, 2024 | finance.yahoo.com

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q4 2023 Earnings Call Transcript

March 15, 2024 | finance.yahoo.com

Aveanna Healthcare Holdings Full Year 2023 Earnings: EPS Misses Expectations

March 15, 2024 | finance.yahoo.com

Q4 2023 Aveanna Healthcare Holdings Inc Earnings Call

March 14, 2024 | finanznachrichten.de

Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Fourth Quarter 2023 Financial Results and 2024 Outlook

March 14, 2024 | msn.com

Aveanna Healthcare reports mixed Q4 results; initiates FY24 outlook

March 14, 2024 | finance.yahoo.com

Aveanna Healthcare Holdings Inc (AVAH) Reports Q4 and Full Year 2023 Earnings, Forecasts Growth ...

March 14, 2024 | globenewswire.com

Aveanna Healthcare Holdings Announces Fourth Quarter 2023 Financial Results and 2024 Outlook

February 22, 2024 | finance.yahoo.com

Aveanna Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call

February 22, 2024 | globenewswire.com

Aveanna Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call

January 7, 2024 | finance.yahoo.com

Are Investors Undervaluing Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) By 47%?

December 16, 2023 | benzinga.com

Aveanna Healthcare Hldgs Stock (NASDAQ:AVAH) Dividends: History, Yield and Dates

December 13, 2023 | msn.com

JP Morgan Downgrades Aveanna Healthcare Holdings (AVAH)

December 11, 2023 | markets.businessinsider.com

Aveanna Healthcare Promotes Matt Buckhalter To CFO

December 8, 2023 | news.yahoo.com

JOB ALERT: Aveanna Healthcare in Gilmer needs a Private Duty Nurse/LVN

December 1, 2023 | benzinga.com

Aveanna Healthcare Hldgs Stock (NASDAQ:AVAH) Earnings Dates and Earning Calls

November 15, 2023 | markets.businessinsider.com

RBC Capital Keeps Their Hold Rating on Aveanna Healthcare Holdings (AVAH)

November 14, 2023 | finance.yahoo.com

Has Aveanna Healthcare (AVAH) Outpaced Other Medical Stocks This Year?

See More Headlines

Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/14/2024
Today: 4/19/2024
Next Earnings (Confirmed): 5/09/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Home health care services
Sub-Industry: N/A
Current Symbol: NASDAQ:AVAH
CUSIP: N/A
CIK: 1832332
Web: www.aveanna.com
Phone: 770-441-1580
Fax: N/A
Employees: 33,500
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $1.80
High Stock Price Target: $3.00
Low Stock Price Target: $1.00
Potential Upside/Downside: -21.4%
Consensus Rating: Reduce
Rating Score (0-4): 1.67
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.71)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-134,520,000.00
Net Margins: -7.10%
Pretax Margin: -7.33%
Return on Equity: N/A
Return on Assets: -1.86%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.89
Quick Ratio: 0.89

Sales & Book Value

Annual Sales: $1.90 billion
Price / Sales: 0.23
Cash Flow: $0.59 per share
Price / Cash Flow: 3.85
Book Value: ($0.68) per share
Price / Book: -3.37

Miscellaneous

Outstanding Shares: 192,380,000
Free Float: 177,373,000
Market Cap: $440.55 million
Optionable: Optionable
Beta: 2.03

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Rodney D. Windley (Age 76)
Executive Chairman
Comp: $120.5k
Mr. Jeffrey S. Shaner (Age 51)
CEO & Director
Comp: $1.1M
Mr. Ed Reisz (Age 65)
Chief Administrative Officer
Comp: $649.39k
Mr. Matthew Buckhalter (Age 35)
CFO & Principal Financial Officer
Ms. Deborah Stewart (Age 40)
Senior VP & Principal Accounting Officer
Mr. Patrick A. Cunningham (Age 68)
Chief Compliance Officer
Ms. Korey Hinz
President of Medical Solutions
Ms. Kristy Rohwedder
President of Private Duty Nursing
Mr. Shane Brinkerhoff
President of Home Health & Hospice
Ms. Rachel Witt
Chief Clinical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

AVAH Stock Analysis - Frequently Asked Questions

Should I buy or sell Aveanna Healthcare stock right now?: 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" AVAH shares.
View AVAH analyst ratings or view top-rated stocks.
What is Aveanna Healthcare's stock price target for 2024?: 6 brokerages have issued 12-month price targets for Aveanna Healthcare's shares. Their AVAH share price targets range from $1.00 to $3.00. On average, they predict the company's share price to reach $1.80 in the next year. This suggests that the stock has a possible downside of 21.4%.
View analysts price targets for AVAH or view top-rated stocks among Wall Street analysts.
How have AVAH shares performed in 2024?: Aveanna Healthcare's stock was trading at $2.68 at the beginning of 2024. Since then, AVAH stock has decreased by 14.6% and is now trading at $2.29.
View the best growth stocks for 2024 here.
When is Aveanna Healthcare's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our AVAH earnings forecast.
How can I listen to Aveanna Healthcare's earnings call?: Aveanna Healthcare will be holding an earnings conference call on Thursday, May 9th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13745298".

How were Aveanna Healthcare's earnings last quarter?: Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) announced its quarterly earnings data on Thursday, March, 14th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. The business earned $478.84 million during the quarter, compared to analyst estimates of $464.33 million.
What guidance has Aveanna Healthcare issued on next quarter's earnings?: Aveanna Healthcare updated its FY 2024 earnings guidance on Thursday, March, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $2.0 billion.
When did Aveanna Healthcare IPO?: Aveanna Healthcare (AVAH) raised $478 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse acted as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.
How do I buy shares of Aveanna Healthcare?: Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AVAH) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial